TECTONIC THERAPEUTIC, INC. Depreciation
TECTONIC THERAPEUTIC, INC. (TECX) reported Depreciation of $281.00 thousand for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2024-11-12
- TECTONIC THERAPEUTIC, INC. depreciation for the quarter ending 2024-09-30 was $281.00K, a 10.20% increase year-over-year.
- TECTONIC THERAPEUTIC, INC. depreciation for the quarter ending 2024-06-30 was $264.00K, a 7.32% increase year-over-year.
- TECTONIC THERAPEUTIC, INC. depreciation for the quarter ending 2023-09-30 was $255.00K.
- TECTONIC THERAPEUTIC, INC. depreciation for the quarter ending 2023-06-30 was $246.00K.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month |
|---|---|---|---|
| 2024-09-30 | $281.00K 10-Q · filed 2024-11-12 | $545.00K derived: sum of 2 quarters · filed 2024-11-12 | $808.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $264.00K 10-Q · filed 2024-08-14 | $526.00K 10-Q · filed 2024-08-14 | |
| 2023-09-30 | $255.00K 10-Q · filed 2024-11-12 | $501.00K derived: sum of 2 quarters · filed 2024-11-12 | $732.00K 10-Q · filed 2024-11-12 |
| 2023-06-30 | $246.00K 10-Q · filed 2024-08-14 | $476.00K 10-Q · filed 2024-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |